India to push for action against terror at G-20

November 15, 2015

New Delhi, Nov 15: After a series of deadly terror attacks in Paris, India is set to raise its pitch to seek stronger global actions against the menace, with Prime Minister Narendra Modi likely to call upon G-20 leaders assembling in Turkey to push for early adoption of the long-pending Comprehensive Convention on International Terrorism by the United Nations.

namoThe G-20 summit at Antalya in Turkey on Sunday and Monday seems set to be overshadowed by Paris attacks and Modi is likely to stress that the fight against terrorism and sponsors of terrorism will require greater and more effective international cooperation. He will argue that the global consensus against terrorism should not be allowed to be held back by a few and the world must unequivocally reject “selective approaches” in combating terrorism.

The prime minister will join other G-20 leaders for a dinner in Antalaya on Sunday to discuss global terrorism and refugee crisis. He is likely to call for international efforts to counter ideology that underpins extremism and draws youths to terrorism, officials told Deccan Herald in New Delhi.

Modi will also refer to anti-India terrorism emanating from Pakistan. He is likely to recall the November 26-29, 2008 terror strikes in Mumbai and call upon world leaders to nudge the Pakistan government to bring to justice the masterminds of the attacks, which had left over 170 killed and countless others injured. The similarity between 26/11 attacks in Mumbai and the string of terror strikes in Paris late on Friday already caught the attention of the international community.

Though the G-20 generally focuses on international economy, Turkey, which currently holds the presidency of the bloc, also included in the agenda issues related terrorism, with particular emphasis in the situation in Iraq and Syria, where Islamic State still controls large territories.

Modi, who was on a visit to London till Saturday, and British Prime Minister David Cameron on Saturday agreed to continue to work together to disrupt all financial and tactical support for terrorist networks to prevent terror strikes and to counter violent extremism, including through exchanges of best practices and technologies.

New Delhi has of late sharpened its criticism against the United Nations Security Council for its “less than robust” response to the threat of terrorism, especially in Asia and Africa.

“The increasing number and brutality of terrorist acts meanwhile vividly illustrates the ineffectiveness of the (UN Security) Council to counter terrorism,” Ashoke Mukherjee, Permanent Representative of India to the UN, told the General Assembly of the international organisation on Thursday.

India is likely to redouble efforts to end impasse in the negotiations over the UN Comprehensive Convention on International Terrorism, which New Delhi has been pushing for since 1996.

Though a draft text of the CCIT is pending before the General Assembly since 2008, negotiations are currently deadlocked, primarily due to disagreements over the definition of terrorism.

“I would like the UN that is celebrating its 70th anniversary to not waste anytime in defining terrorism,” Modi said in London on Saturday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 4,2020

New Delhi, Aug 4: Over 50 per cent of COVID-19 deaths in India have taken place among people aged 60 years and above and 37 per cent deaths have been reported among patients in the age group of 45 to 60 years, Health Ministry said on Tuesday.

Addressing a press conference, Rajesh Bhushan, Secretary, Health Ministry said that 11 per cent COVID-19 deaths took place in the age group of 26 to 44.

The 18 to 25 age group and those below 18 years reported one per cent deaths each.
"Currently, 5,86,298 active COVID-19 cases are in India and over 12 lakh people have recovered.

50 per cent deaths due to COVID19 have taken place among the age group of 60 years or above and 37 per cent deaths took place in the age group between 45 to 60 years," Bhushan said.

"A total of 11 per cent COVID-19 deaths took place in the age group of 26 to 44. Only 1 per cent in 18 to 25 age group and 1 per cent in below the age of 18 years," he added.

Bhushan said that 68 per cent of COVID-19 deaths have been reported among male patients and 32 per cent among female patients which is broadly in line with the global scenario.

The number of recovered COVID-19 patients in India is increasing daily and is now over double the number of active cases.

Bhushan said that the case fatality rate (CFR) is lowest since the first lockdown.

"More than 2 crore COVID-19 tests have been conducted, including more than 6.6 lakh tests in the last 24 hours. Recovered cases are now double of the active cases. 

The case fatality rate (CFR) is lowest since the first lockdown," he said
"This is the first time after the first lockdown that the fatality rate is at the lowest, at 2.10 per cent. The fatality rate has seen a progressive decline and it is continuing, which is a good sign," he added.

According to the World Health Organisation, CFR is a measure of the severity of a disease and is defined as the proportion of reported cases of a specified disease or condition which are fatal within a specified time.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 4,2020

Kota, Jan 4: Following the death of an infant in the morning, the death toll in JK Lon Hospital here has risen to 107, officials said on Saturday.

A three-member state government committee of doctors, who was sent to investigate the matter on December 23 and 24, found that Kota's JK Lone Hospital is short of beds and it requires improvement.

However, the committee gave a clean chit to the doctors for any lapses over the recent death of infants admitted there.

A Central government team reached the hospital on Saturday to take stock of the situation.

As per the government report, at least 91 infants lost their lives at the government hospital in December last year.

Meanwhile, the National Human Rights Commission (NHRC) has issued a notice to Chief Secretary of Rajasthan to submit a detailed report within 4 weeks about the steps being taken to address the issue.

The Commission also asked the Chief Secretary to ensure that such deaths of the children do not recur in future due to lack of infrastructure and health facilities at the hospitals.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.